Developer docs
API playgroundTry for free, no card

Search company profiles

Labplus

Full company profile

uuid0003bcv

Namestring
Labplus
Legal namestring
Labplus S.A.
Websiteurl
labplus.ai
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Labplus S.A. is a Wroclaw, Poland-based medtech company that has developed LabTest Checker, a Class IIa certified medical device (under EU MDR 2017/745) that uses artificial intelligence to interpret laboratory test results in the context of each patient's individual clinical profile. The core technology combines numerical lab results with a personalized medical questionnaire covering conditions, medications, symptoms, and risk factors, then generates context-aware health recommendations and flags clinically significant deviations. The system is validated at 97.45% accuracy and 99.42% safety, with clinical study results peer-reviewed in JMIR and extended to 100+ lab parameters in Q1 2026.

The company operates a B2B enterprise licensing model, distributing LabTest Checker exclusively through partnerships with diagnostic laboratories and healthcare providers via WebAPI integration. The integration reportedly takes an average of eight days and requires zero upfront investment from partner labs, with monthly subscription/usage-based billing. Named enterprise customers include Diagnostyka (CEE's largest diagnostic lab network), Synevo (a leading European diagnostic network), Lab-Med, Radomskie Centrum Onkologii, badaj.to, and uPacjenta. Labplus targets primary customer segments of diagnostic laboratories, healthcare providers, and corporate health programs, with the value proposition centered on converting one-time test interactions into ongoing patient relationships and increasing lab LTV.

The company was founded circa 2018-2022 (sources conflict), is headquartered in Wroclaw, Poland, operates with 11-50 employees, and has raised approximately $1.5M (7M PLN) in pre-seed funding led by LT Capital with participation from Movens Capital and a grant from Poland's National Centre for Research and Development. The company is registered as a Polish joint-stock company (Spółka Akcyjna) with ISO 13485 quality certification from TÜV SÜD, GDPR-compliant data processing, and a Medical Advisory Board led by Prof. Grzegorz Mazur.

Short descriptiontext

Labplus is a Polish medtech company that offers LabTest Checker, a Class IIa-certified AI medical device providing context-aware interpretation of laboratory test results for diagnostic labs and healthcare providers via B2B WebAPI licensing.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersWroclaw, Poland
HQ citystring
Wroclaw
HQ countrystring
Poland
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
lab test interpretation, clinical decision support, medical device software, diagnostic AI platform, healthcare API integration
Industry2 codes
PRIMARYHLACAMAI
Lab Middleware, Instrument Connectivity & Automation
Healthcare & Life Sciences/Digital Health & Health IT/Laboratory Information Systems (LIS/LIMS) & Pathology Informatics
SECONDARYHLAGAJAG
Lab Automation, Instrument Control & Workflow Orchestration Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
NAICS code1 code
  • Medical Laboratories621511
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Clinical Decision Support Software
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1LabTest Checker B2B Licensing
TypeSubscription Recurring
Description

Labplus provides its LabTest Checker technology to laboratory networks and healthcare providers through B2B licensing arrangements. The company integrates via WebAPI into partner platforms with no upfront investment required for partners, indicating a subscription or usage-based revenue model.

labplus.health
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure, Others
Pricing details1 tier
1B2B Enterprise Licensing
ModelSubscriptionBilling cadenceMonthly
Notes

0 Euro upfront investment required for integration. Pricing based on enterprise agreements with laboratory networks and healthcare providers.

labplus.health
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1LabTest Checker
Description

AI-powered laboratory test result interpretation system that provides patients with diagnoses, recommendations, and next-step guidance based on their lab results combined with personalized medical interviews. Certified as a Class IIa medical device under EU MDR 2017/745.

labplus.health
Core offering1 text field

Labplus develops LabTest Checker, a certified Class IIa medical device under EU MDR 2017/745 that uses AI to interpret laboratory test results. The system combines numerical lab parameters with a personalized medical questionnaire (conditions, medications, symptoms, risk factors) to deliver context-aware health insights, clinically relevant follow-up test recommendations in 78.3% of cases, and prophylactic screening suggestions. The product is licensed to diagnostic laboratories, hospitals, and corporate health platforms via WebAPI integration with an 8-day average deployment time and zero upfront investment for partners.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 97.45% accuracy rate (acceptance threshold ≥90%)
+6 more records
Product overview1 text field

Labplus offers a single unified product: LabTest Checker, a Class IIa medical device that provides AI-powered interpretation of laboratory test results. The system combines numerical lab data with a personalized patient medical questionnaire to generate context-aware health insights and actionable recommendations. It is designed for integration with laboratory and healthcare provider systems via WebAPI, and serves adult patients (18+) across Poland and international markets.

Product and service1 record
1LabTest Checker
CategoryClinical Decision Support Software / Medical Device Software
Description

LabTest Checker is a certified Class IIa medical device (EU MDR 2017/745, Notified Body 2443) that transforms raw laboratory test results into personalized health insights and next-step recommendations for adult patients (18+, except pregnancy). It combines numerical lab results with a personalized medical questionnaire covering conditions, medications, symptoms, and risk factors to deliver context-aware interpretations. Clinically validated with 97.45% accuracy, 99.42% safety, and 99.32% sensitivity for urgent conditions. Delivered to diagnostic laboratories, hospitals, oncology centers, and corporate health platforms via WebAPI integration with an 8-day average deployment time and zero upfront investment for partners.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical validation partner for LabTest Checker. Conducted clinical study that validated the system, with results peer-reviewed and published in JMIR (Journal of Medical Internet Research). Validation extended to 100+ lab parameters in Q1 2026.

Strategic tierMinorTypeOthers
Description

Notified Body providing ISO 13485 quality system certification for Labplus as a medical device manufacturer.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Mediktor provides an AI-powered pre-diagnosis and triage engine that evaluates patient symptoms and clinical inputs to suggest likely conditions. Comparable to Labplus because both deploy regulated clinical AI to interpret patient health inputs and route people to the right next step, and both target enterprise healthcare customers.

TypeDirect peer
Description

Prognos applies AI to laboratory and claims data to surface clinical insights for providers, payers, and life sciences. Directly comparable because both commercialise AI-driven interpretation of lab data as a paid B2B service to clinical stakeholders.

TypeDirect peer
Description

Ada Health offers an AI symptom assessment and clinical reasoning platform used by healthcare providers and consumers. Comparable to Labplus because both deliver regulated AI health interpretation that produces patient-facing guidance and next-step recommendations.

4K Health
TypeEmerging player
Description

K Health combines AI-driven intake and lab-result interpretation with telehealth consultations for consumers and enterprise health plans. Comparable because it pairs AI interpretation of clinical inputs with downstream care navigation, similar to Labplus's interpretation-plus-consultation model.

5Dascena
TypeEmerging player
Description

Dascena builds machine-learning models on EHR and lab data to predict patient deterioration and guide earlier interventions. Comparable because both operate in regulated clinical AI and turn lab/EHR data into actionable clinical decisions for providers.

TypeBroad incumbent
Description

Health Catalyst is a healthcare data and analytics platform that ingests lab, clinical, and operational data to drive decision support at hospitals and health systems. Broader incumbent in the same analytical-decision-support category that Labplus targets at the narrower lab-interpretation layer.

7Tempus Labs
TypeBroad incumbent
Description

Tempus applies AI to clinical and molecular data to support diagnostics and precision medicine across provider and life-science customers. Broader incumbent in clinical AI interpretation; comparable to Labplus because both monetise AI-driven interpretation of diagnostic data in regulated settings.

TypeBroad incumbent
Description

Siemens Healthineers is a major diagnostics and imaging vendor with an installed base of laboratory instruments and growing clinical AI capabilities. Relevant incumbent because it sells into the same diagnostic laboratories that Labplus serves and could natively bundle interpretation features.

TypeBroad incumbent
Description

Roche Diagnostics is one of the world's largest in-vitro diagnostics providers with a global lab services footprint. Comparable as a broad incumbent that controls much of the lab ecosystem Labplus sells into and could potentially bundle or compete with lab interpretation software.

TypeOthers
Description

LabWare is a major Laboratory Information Management System (LIMS) vendor used by clinical and analytical labs worldwide. Adjacent because LabWare sits in the same IT stack that Labplus's WebAPI integrates with; potential partner or competitor depending on how LIS vendors evolve their own result-interpretation features.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Labplus

Clinical Decision Support Softwarelabplus.ai

Labplus is a Polish medtech company that offers LabTest Checker, a Class IIa-certified AI medical device providing context-aware interpretation of laboratory test results for diagnostic labs and healthcare providers via B2B WebAPI licensing.

What Labplus does

Labplus S.A. is a Wroclaw, Poland-based medtech company that has developed LabTest Checker, a Class IIa certified medical device (under EU MDR 2017/745) that uses artificial intelligence to interpret laboratory test results in the context of each patient's individual clinical profile. The core technology combines numerical lab results with a personalized medical questionnaire covering conditions, medications, symptoms, and risk factors, then generates context-aware health recommendations and flags clinically significant deviations. The system is validated at 97.45% accuracy and 99.42% safety, with clinical study results peer-reviewed in JMIR and extended to 100+ lab parameters in Q1 2026.

The company operates a B2B enterprise licensing model, distributing LabTest Checker exclusively through partnerships with diagnostic laboratories and healthcare providers via WebAPI integration. The integration reportedly takes an average of eight days and requires zero upfront investment from partner labs, with monthly subscription/usage-based billing. Named enterprise customers include Diagnostyka (CEE's largest diagnostic lab network), Synevo (a leading European diagnostic network), Lab-Med, Radomskie Centrum Onkologii, badaj.to, and uPacjenta. Labplus targets primary customer segments of diagnostic laboratories, healthcare providers, and corporate health programs, with the value proposition centered on converting one-time test interactions into ongoing patient relationships and increasing lab LTV.

The company was founded circa 2018-2022 (sources conflict), is headquartered in Wroclaw, Poland, operates with 11-50 employees, and has raised approximately $1.5M (7M PLN) in pre-seed funding led by LT Capital with participation from Movens Capital and a grant from Poland's National Centre for Research and Development. The company is registered as a Polish joint-stock company (Spółka Akcyjna) with ISO 13485 quality certification from TÜV SÜD, GDPR-compliant data processing, and a Medical Advisory Board led by Prof. Grzegorz Mazur.

Labplus firmographics

Firmographics
Name
Labplus
Legal name
Labplus S.A.
Website
https://labplus.ai
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
11–50 employees
Short description
Labplus is a Polish medtech company that offers LabTest Checker, a Class IIa-certified AI medical device providing context-aware interpretation of laboratory test results for diagnostic labs and healthcare providers via B2B WebAPI licensing.
Ownership category
akta.pro rank

Labplus industry classification

Industry
Product category
Clinical Decision Support Software
NAICS
Medical Laboratories (621511)
SIC
Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLACAMAI
Lab Middleware, Instrument Connectivity & Automation
Healthcare & Life Sciences/Digital Health & Health IT/Laboratory Information Systems (LIS/LIMS) & Pathology Informatics
SECONDARYHLAGAJAG
Lab Automation, Instrument Control & Workflow Orchestration Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

Keywords

  • Lab test interpretation
  • Clinical decision support
  • Medical device software
  • Diagnostic AI platform
  • Healthcare API integration

Where Labplus is headquartered

Location

Headquarters

HQ city
Wroclaw
HQ country
Poland
HQ region
Europe

Offices1 record

Markets served

Labplus business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure, Others

Revenue model

  1. LabTest Checker B2B Licensing: Labplus provides its LabTest Checker technology to laboratory networks and healthcare providers through B2B licensing arrangements. The company integrates via WebAPI into partner platforms with no upfront investment required for partners, indicating a subscription or usage-based revenue model.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyB2B Enterprise Licensing

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Labplus product offering

Product offering

Core offering

Labplus develops LabTest Checker, a certified Class IIa medical device under EU MDR 2017/745 that uses AI to interpret laboratory test results. The system combines numerical lab parameters with a personalized medical questionnaire (conditions, medications, symptoms, risk factors) to deliver context-aware health insights, clinically relevant follow-up test recommendations in 78.3% of cases, and prophylactic screening suggestions. The product is licensed to diagnostic laboratories, hospitals, and corporate health platforms via WebAPI integration with an 8-day average deployment time and zero upfront investment for partners.

Product overview

Labplus offers a single unified product: LabTest Checker, a Class IIa medical device that provides AI-powered interpretation of laboratory test results. The system combines numerical lab data with a personalized patient medical questionnaire to generate context-aware health insights and actionable recommendations. It is designed for integration with laboratory and healthcare provider systems via WebAPI, and serves adult patients (18+) across Poland and international markets.

Differentiator

Problem solved

Functional benefit

Brands

  • LabTest Checker: AI-powered laboratory test result interpretation system that provides patients with diagnoses, recommendations, and next-step guidance based on their lab results combined with personalized medical interviews. Certified as a Class IIa medical device under EU MDR 2017/745.

Products and services

  • LabTest Checker LabTest Checker is a certified Class IIa medical device (EU MDR 2017/745, Notified Body 2443) that transforms raw laboratory test results into personalized health insights and next-step recommendations for adult patients (18+, except pregnancy). It combines numerical lab results with a personalized medical questionnaire covering conditions, medications, symptoms, and risk factors to deliver context-aware interpretations. Clinically validated with 97.45% accuracy, 99.42% safety, and 99.32% sensitivity for urgent conditions. Delivered to diagnostic laboratories, hospitals, oncology centers, and corporate health platforms via WebAPI integration with an 8-day average deployment time and zero upfront investment for partners.

Quantifiable outcome

  • 97.45% accuracy rate (acceptance threshold ≥90%)
  • +6 more outcomes

Companies that use Labplus

Customer profile

Named customers7 records

Segments3 records

Ideal customer profiles3 records

Labplus technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature3 records

Labplus partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and minor.

  • Medical University of SilesiacoreStrategic or Co-development PartnerClinical validation partner for LabTest Checker. Conducted clinical study that validated the system, with results peer-reviewed and published in JMIR (Journal of Medical Internet Research). Validation extended to 100+ lab parameters in Q1 2026.
  • TÜV SÜDminorOthersNotified Body providing ISO 13485 quality system certification for Labplus as a medical device manufacturer.

Scale indicators8 records

Recent moves6 records

Expansion highlights3 records

Labplus competitors and assessment

Company assessment

Direct peers

  • Mediktor: Mediktor provides an AI-powered pre-diagnosis and triage engine that evaluates patient symptoms and clinical inputs to suggest likely conditions. Comparable to Labplus because both deploy regulated clinical AI to interpret patient health inputs and route people to the right next step, and both target enterprise healthcare customers.
  • Prognos Health: Prognos applies AI to laboratory and claims data to surface clinical insights for providers, payers, and life sciences. Directly comparable because both commercialise AI-driven interpretation of lab data as a paid B2B service to clinical stakeholders.
  • Ada Health: Ada Health offers an AI symptom assessment and clinical reasoning platform used by healthcare providers and consumers. Comparable to Labplus because both deliver regulated AI health interpretation that produces patient-facing guidance and next-step recommendations.

Emerging players

  • K Health: K Health combines AI-driven intake and lab-result interpretation with telehealth consultations for consumers and enterprise health plans. Comparable because it pairs AI interpretation of clinical inputs with downstream care navigation, similar to Labplus's interpretation-plus-consultation model.
  • Dascena: Dascena builds machine-learning models on EHR and lab data to predict patient deterioration and guide earlier interventions. Comparable because both operate in regulated clinical AI and turn lab/EHR data into actionable clinical decisions for providers.

Broad incumbents

  • Health Catalyst: Health Catalyst is a healthcare data and analytics platform that ingests lab, clinical, and operational data to drive decision support at hospitals and health systems. Broader incumbent in the same analytical-decision-support category that Labplus targets at the narrower lab-interpretation layer.
  • Tempus Labs: Tempus applies AI to clinical and molecular data to support diagnostics and precision medicine across provider and life-science customers. Broader incumbent in clinical AI interpretation; comparable to Labplus because both monetise AI-driven interpretation of diagnostic data in regulated settings.
  • Siemens Healthineers: Siemens Healthineers is a major diagnostics and imaging vendor with an installed base of laboratory instruments and growing clinical AI capabilities. Relevant incumbent because it sells into the same diagnostic laboratories that Labplus serves and could natively bundle interpretation features.
  • Roche Diagnostics: Roche Diagnostics is one of the world's largest in-vitro diagnostics providers with a global lab services footprint. Comparable as a broad incumbent that controls much of the lab ecosystem Labplus sells into and could potentially bundle or compete with lab interpretation software.

Others

  • LabWare: LabWare is a major Laboratory Information Management System (LIMS) vendor used by clinical and analytical labs worldwide. Adjacent because LabWare sits in the same IT stack that Labplus's WebAPI integrates with; potential partner or competitor depending on how LIS vendors evolve their own result-interpretation features.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Labplus social profiles

Digital presence

Labplus compliance and trust

Trust signal

Compliance4 records

Labplus financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Labplus leadership team

Management profile

Number of profiles

Profiles4 records

Labplus funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Labplus M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Labplus

What does Labplus do?

Labplus develops LabTest Checker, a certified Class IIa medical device under EU MDR 2017/745 that uses AI to interpret laboratory test results. The system combines numerical lab parameters with a personalized medical questionnaire (conditions, medications, symptoms, risk factors) to deliver context-aware health insights, clinically relevant follow-up test recommendations in 78.3% of cases, and prophylactic screening suggestions. The product is licensed to diagnostic laboratories, hospitals, and corporate health platforms via WebAPI integration with an 8-day average deployment time and zero upfront investment for partners.

Is Labplus a public or private company?

Labplus is a private company. It is classified as venture growth investor backed and is currently operating.

When was Labplus founded?

Labplus was founded in 2018. It employs 11 to 50 people.

Where is Labplus based?

Labplus is headquartered in Wroclaw, Poland, in the Europe region.

How does Labplus make money?

One revenue line is on record: labTest Checker B2B Licensing.

Who are Labplus's main competitors?

Direct peers on record are Mediktor, Prognos Health and Ada Health. Emerging players are K Health and Dascena. Broad incumbents are Health Catalyst, Tempus Labs, Siemens Healthineers and Roche Diagnostics. LabWare is listed as an others.

Does Labplus have an API?

Yes. Labplus offers a WebAPI integration for partners (labs and healthcare providers) to connect their systems. The integration is described as seamless with minimal effort required. Technical documentation spans 3 pages. Integration typically takes 8 days on average with direct IT specialist support provided.

What industry is Labplus in?

Labplus's product category is Clinical Decision Support Software. Its primary akta.pro industry code is HLACAMAI, Lab Middleware, Instrument Connectivity & Automation, with a secondary code of HLAGAJAG, Lab Automation, Instrument Control & Workflow Orchestration Software. Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
RzeczpospolitaLekarza zastąpi AI. Polacy przeanalizują wyniki pacjenta onlineSiddarth Agrawal's LabTest Checker uses AI to analyze online lab results for patients on uPacjenta, generating diagnoses and recommendations. The company raised over 7 million zł in pre-seed funding and aims to reduce unnecessary doctor visits. The tool is developed with support from two Polish medical universities.AinPolish healthtech Labplus raises $1.5M for its AI lab solutionPolish healthtech startup Labplus has raised $1.5 million in a pre-seed funding round led by LT Capital and supported by a grant from the National Centre for Research and Development. The company develops AI algorithms to automate the analysis of lab test results, with its diagnostic engine reportedly matching physician diagnoses in over 90% of cases. Labplus plans to use the funds to further develop its technology, acquire B2B customers, and support international expansion.Think TechLabplus pozyskał 7 mln zł na rozwój LabTest CheckerLabplus raised 7 million PLN in pre-seed funding and a grant from the National Centre for Research and Development to develop its AI tool LabTest Checker, which analyzes lab results online. The tool is now available on the uPacjenta platform, with users from Diagnostyka and Medonet expected to access it within weeks. The company plans to close a seed round this year to expand B2B clients and go international.MamStartupLabplus pozyskał ponad 7 mln zł. Startup rozwija technologię do interpretacji wyników badań laboratoryjnychLabplus secured over 7 million PLN in pre-seed funding from LT Capital and a grant from the National Centre for Research and Development to commercialize its AI-based laboratory test interpretation technology. The company has launched its first product, LabTest Checker, in collaboration with partners uPacjenta, Diagnostyka, and Medonet, aiming to close a seed round this year for further expansion. This investment supports the scaling of diagnostic tools designed to reduce healthcare costs and improve patient outcomes by providing immediate medical insights.